| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 365 | 378 | 409 | 400 | 432 | 455 | 492 | 459 | 489 | 526 | 565 | 558 | 653 | 655 | 714 | 735 | 776 | 782 | 829 | 791 | 750 | 398 | 611 | 755 | 846 | 867 | 952 | 967 | 951 | 1,041 | 1,173 | 1,140 | 1,236 | 1,249 | 1,324 | 1,222 | 1,273 | 1,331 | 1,424 | 1,353 | 1,503 | 1,532 |
| Expenses | 326 | 344 | 360 | 358 | 392 | 402 | 426 | 406 | 425 | 473 | 502 | 502 | 597 | 607 | 640 | 657 | 676 | 675 | 702 | 684 | 659 | 486 | 575 | 648 | 698 | 728 | 774 | 787 | 768 | 842 | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,004 | 1,092 | 1,028 | 1,126 | 1,171 |
| EBITDA | 39 | 34 | 49 | 42 | 40 | 54 | 66 | 53 | 64 | 53 | 63 | 56 | 56 | 49 | 74 | 79 | 101 | 107 | 127 | 107 | 92 | -87 | 36 | 107 | 148 | 139 | 179 | 180 | 182 | 200 | 275 | 266 | 290 | 286 | 327 | 297 | 318 | 327 | 332 | 325 | 377 | 361 |
| Operating Profit % | 10 % | 8 % | 11 % | 10 % | 8 % | 11 % | 13 % | 11 % | 12 % | 9 % | 10 % | 9 % | 8 % | 7 % | 10 % | 10 % | 12 % | 13 % | 15 % | 13 % | 11 % | -23 % | 4 % | 14 % | 17 % | 15 % | 18 % | 18 % | 18 % | 19 % | 21 % | 23 % | 23 % | 22 % | 24 % | 23 % | 23 % | 23 % | 22 % | 23 % | 24 % | 22 % |
| Depreciation | 19 | 18 | 18 | 19 | 21 | 19 | 20 | 20 | 21 | 22 | 29 | 24 | 26 | 33 | 34 | 35 | 36 | 41 | 43 | 46 | 55 | 46 | 46 | 47 | 45 | 45 | 46 | 46 | 47 | 48 | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 83 | 84 |
| Interest | 12 | 9 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 8 | 8 | 21 | 17 | 18 | 18 | 18 | 22 | 22 | 21 | 21 | 20 | 19 | 19 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 |
| Profit Before Tax | 10 | 10 | 26 | 20 | 13 | 29 | 41 | 28 | 37 | 21 | 26 | 24 | 9 | -1 | 22 | 26 | 47 | 43 | 62 | 40 | 16 | -153 | -30 | 42 | 85 | 77 | 116 | 117 | 119 | 137 | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 |
| Tax | 11 | 11 | 16 | 14 | 8 | 12 | 15 | 11 | 15 | 10 | 10 | 10 | -1 | 3 | 8 | 13 | 10 | 13 | 17 | 9 | 4 | -34 | -26 | 1 | 17 | 1 | 17 | 20 | 50 | 27 | 42 | 36 | 40 | 22 | 22 | 21 | 34 | 30 | 33 | 26 | 57 | 35 |
| Net Profit | -1 | -1 | 10 | 6 | 5 | 17 | 27 | 17 | 22 | 11 | 17 | 14 | 10 | -4 | 14 | 13 | 37 | 30 | 45 | 31 | 12 | -120 | -3 | 41 | 68 | 76 | 99 | 98 | 69 | 111 | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 |
| EPS in ₹ | 0.00 | -0.03 | 0.52 | 0.29 | 0.25 | 0.85 | 1.31 | 0.84 | 1.10 | 0.54 | 0.82 | 0.70 | 0.48 | -0.21 | 0.67 | 0.63 | 1.83 | 1.49 | 2.23 | 1.55 | 0.59 | -5.90 | -0.17 | 2.01 | 3.35 | 3.75 | 4.89 | 4.80 | 3.40 | 5.45 | 8.31 | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.50 | 9.71 | 9.68 |
Narayana Hrudayalaya
Narayana Hrudayalaya
1,845.80
+32.10
(1.77%)
Market Cap
37,720.92 Cr
EPS
38.90
PE Ratio
46.86
Dividend Yield
0.25 %
Industry
Healthcare Services52 Week High
2,370.20
52 Week Low
1,185.00
PB Ratio
10.22
Debt to Equity
0.62
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,221.40 | #1 1,18,738.02 | 100.09 | 7,184.10 | #1 28.68 | 1,076 | 30.34 | 44.50 | |
7,851.00 | 1,12,885.33 | 72.40 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 65.57 | |
915.15 | 69,089.99 | 76.32 | 7,849.70 | 13.25 | 809 | #1 53.33 | 58.90 | |
1,845.80 | #4 37,720.92 | #1 46.86 | #4 5,575.00 | #10 12.29 | #4 790 | #7 -2.38 | 47.32 | |
1,396.30 | 37,502.86 | 65.20 | 3,692.32 | 21.40 | 486 | 49.58 | 60.96 | |
600.70 | 31,123.53 | 87.36 | 4,286.70 | 15.12 | 337 | -98.18 | 50.08 | |
756.60 | 30,274.51 | 80.01 | 3,067.00 | 21.98 | 415 | -10.71 | 55.36 | |
1,525.30 | 15,489.68 | 61.90 | 1,566.90 | 17.46 | 244 | 35.52 | 48.08 | |
679.85 | 9,478.15 | 254.21 | 2,218.14 | 12.97 | 28 | -55.88 | 71.25 | |
1,415.90 | 9,283.49 | 47.85 | 1,290.20 | 17.77 | 194 | -1.57 | 45.78 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
12.29 %
Net Income Growth
0.48 %
Cash Flow Change
-7.58 %
ROE
-20.08 %
ROCE
-17.99 %
EBITDA Margin (Avg.)
-0.28 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 | 7,265 |
| Fixed Assets | 913 | 1,055 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 |
| Current Assets | 260 | 286 | 302 | 479 | 527 | 586 | 665 | 909 | 1,294 | 1,946 | 2,550 |
| Capital Work in Progress | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 |
| Investments | 0 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 |
| Other Assets | 437 | 401 | 416 | 644 | 725 | 701 | 669 | 951 | 1,315 | 1,615 | 1,829 |
| Total Liabilities | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 | 7,265 |
| Current Liabilities | 343 | 315 | 323 | 510 | 510 | 602 | 703 | 780 | 987 | 1,110 | 1,193 |
| Non Current Liabilities | 258 | 365 | 361 | 989 | 1,045 | 1,153 | 946 | 861 | 1,042 | 1,629 | 2,444 |
| Total Equity | 769 | 876 | 963 | 1,036 | 1,082 | 1,137 | 1,121 | 1,489 | 2,132 | 2,885 | 3,628 |
| Reserve & Surplus | 568 | 674 | 761 | 833 | 878 | 933 | 917 | 1,286 | 1,928 | 2,681 | 3,423 |
| Share Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 8 | -2 | 59 | -4 | 97 | 205 |
| Investing Activities | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 |
| Operating Activities | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 |
| Financing Activities | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 489 | 544 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.91 % | 10.01 % | 9.68 % | 9.44 % | 9.66 % | 10.46 % |
| DIIs | 14.80 % | 15.55 % | 16.15 % | 14.61 % | 13.76 % | 13.43 % | 16.18 % | 14.58 % | 14.14 % | 11.95 % | 10.89 % | 9.46 % | 9.51 % | 8.23 % | 7.90 % | 8.69 % | 8.52 % | 8.09 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.64 % | 4.97 % | 4.85 % | 5.11 % | 5.92 % | 6.87 % | 5.86 % | 6.93 % | 7.10 % | 7.99 % | 8.46 % | 9.04 % | 10.00 % | 11.68 % | 12.13 % | 11.58 % | 11.47 % | 11.18 % |
| Others | 16.71 % | 15.63 % | 15.14 % | 16.43 % | 16.46 % | 15.85 % | 14.11 % | 14.64 % | 14.90 % | 16.20 % | 5.20 % | 17.65 % | 5.73 % | 6.23 % | 6.43 % | 6.43 % | 6.50 % | 6.42 % |
| No of Share Holders | 0 | 36,360 | 44,526 | 43,565 | 43,807 | 52,747 | 65,173 | 68,130 | 75,370 | 86,631 | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 | 1,85,787 | 2,05,639 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 | 1 | 2.5 | 4 | 4.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.4 | 0.25 | 0.00 | 0.13 | 0.19 | 0.24 | 0.25 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2025 |  Annual General Meeting | NA | 29 Aug 2025 | 1,724.30 | 1,844.25 |
| 23 Aug 2022 |  Dividend | ₹ 1.00 /share | 22 Aug 2022 | 659.80 | 705.15 |
| 07 Jul 2023 | Dividend | ₹ 2.50 /share | 07 Jul 2023 | 767.85 | 1,012.95 |
| 02 Aug 2024 | Dividend | ₹ 4.00 /share | 02 Aug 2024 | 1,255.10 | 1,252.75 |
| 30 Aug 2024 | Annual General Meeting | NA | 30 Aug 2024 | 1,255.10 | 1,265.50 |
| 31 Oct 2024 |  Quarterly Result Announcement | NA | 31 Oct 2024 | 1,236.20 | 1,222.55 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 1,372.70 | 1,329.00 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 1,790.70 | 1,724.30 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 1,991.45 | 1,916.05 |
| 01 Aug 2025 | Dividend | ₹ 4.50 /share | 01 Aug 2025 | 1,724.30 | 1,916.05 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
4 days agoLetter To Shareholders- Weblink Of 25Th AGM Notice And Annual Report For FY 2024-257 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Aug 07, 2025Regulation 53 (1) Annual Report.Aug 07, 2025
Aug 07, 2025Reg. 34 (1) Annual Report.Aug 07, 2025
Aug 07, 2025Notice Of The 25Th Annual General Meeting (AGM) Of The Company For F.Y. 2024-25Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 03, 2025
Aug 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Aug 01, 2025Recommendation By The Board For The Issuance Of Non-Convertible Securities.Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30 2025
Aug 01, 2025
Aug 01, 2025Unaudited Financial Results For The Quarter Ended June 30 2025
Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2025
Jul 29, 2025Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025 And Fund Raising.Jul 28, 2025
Jul 28, 2025Communication To Shareholders - Intimation On Tax Deduction On DividendJul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Rumour verification - Regulation 30(11)Jun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2025
Jun 02, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
May 27, 2025Clarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.May 27, 2025
May 27, 2025Clarification sought from Narayana Hrudayalaya LtdMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
May 26, 2025General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
May 23, 2025General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.May 23, 2025
May 23, 2025Shareholders MeetingMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 23, 2025
May 23, 2025General Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.May 23, 2025
May 23, 2025Record Date - For DividendMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
May 23, 2025Corporate Action-Board approves DividendMay 23, 2025
May 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting For The Financial Results For The Quarter And Year Ended March 312025May 23, 2025
May 23, 2025Technical Indicators
RSI(14)
Neutral 47.32
ATR(14)
Less Volatile 51.35
STOCH(9,6)
Overbought 88.75
STOCH RSI(14)
Overbought 89.47
MACD(12,26)
Bullish 5.52
ADX(14)
Strong Trend 26.83
UO(9)
Bearish 52.68
ROC(12)
Uptrend And Accelerating 4.37
WillR(14)
Overbought -5.94
Mutual Fund Holdings
Nippon India Pharma Fund Direct-Growth 
DSP Small Cap Direct Plan-Growth 
Samco Active Momentum Fund Direct - Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
Axis Multicap Fund Direct-Growth 
UTI Multi Asset Allocation Fund Direct-Growth 
Mirae Asset Multicap Fund Direct - Growth 
Taurus Ethical Fund Direct-Growth 
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth 
Groww ELSS Tax Saver Fund Direct - Growth 
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth 
Bandhan Nifty Alpha 50 Index Fund Direct-Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth 
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth About Narayana Hrudayalaya
Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years,
20 days)
Chairperson NameDEVI PRASAD SHETTY
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
